ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00028925

Public ClinicalTrials.gov record NCT00028925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF (Filgrastim) Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer

Study identification

NCT ID
NCT00028925
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
27 participants

Conditions and interventions

Conditions

Interventions

  • WBRT Radiation
  • carboplatin Drug
  • filgrastim Biological
  • topotecan hydrochloride Drug

Radiation · Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2001
Primary completion
Oct 31, 2005
Completion
Jul 31, 2008
Last update posted
Dec 6, 2016

2001 – 2008

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
MBCCOP-Howard University Cancer Center Washington D.C. District of Columbia 20060
Mayo Clinic Jacksonville Florida 32224
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
Wichita Community Clinical Oncology Program Wichita Kansas 67214-3882
CCOP - Ochsner New Orleans Louisiana 70121
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
CentraCare Health Plaza Saint Cloud Minnesota 56303
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106
Medcenter One Health System Bismarck North Dakota 58501
CCOP - Merit Care Hospital Fargo North Dakota 58122
Altru Health Systems Grand Forks North Dakota 58201
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456
Allegheny General Hospital Pittsburgh Pennsylvania 15212-4772
Rapid City Regional Hospital Rapid City South Dakota 57709

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00028925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2016 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00028925 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →